1. A 52‐week multicenter randomized controlled study of the efficacy and safety of add‐on dutasteride and imidafenacin to tamsulosin in patients with benign prostatic hyperplasia with remaining overactive bladder symptoms (DIrecT study). Issue 3 (24th October 2018) Authors: Yamanishi, Tomonori; Asakura, Hirotaka; Seki, Narihito; Tokunaga, Shoji Journal: LUTS Issue: Volume 11:Issue 3(2019) Page Start: 115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A prospective, single‐center, randomized clinical trial to evaluate the efficacy of three types of laser vaporization surgeries using a 180‐W GreenLight XPS laser, a 300‐W diode laser, and a 200‐W thulium laser for the treatment of benign prostatic hyperplasia. Issue 5 (19th June 2022) Authors: Okada, Tatsunori; Koura, Mikifumi; Sumikawa, Ryota; Masaoka, Hiroyuki; Song, Yoohyun; Dejima, Takashi; Seki, Narihito Journal: LUTS Issue: Volume 14:Issue 5(2022) Page Start: 373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dissociated response among multiple metastatic lesions in the patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors. (11th September 2022) Authors: Negishi, Takahito; Nakagawa, Tohru; Nishiyama, Naotaka; Kitamura, Hiroshi; Okajima, Eijiro; Furubayashi, Nobuki; Hori, Yoshifumi; Kuroiwa, Kentarou; Son, Yuhyon; Seki, Narihito; Tomoda, Toshihisa; Nakamura, Motonobu Journal: Japanese journal of clinical oncology Issue: Volume 52:Number 12(2022) Page Start: 1430 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effectiveness and safety of radium‐223 dichloride in patients with castration‐resistant prostate cancer and bone metastases in real‐world practice: A multi‐institutional study. (28th October 2022) Authors: Matsumoto, Takashi; Hori, Yoshifumi; Shiota, Masaki; Blas, Leandro; Nakamura, Motonobu; Seki, Narihito; Kuroiwa, Kentaro; Yokomizo, Akira; Morokuma, Futoshi; Kiyoshima, Keijiro; Eto, Masatoshi Journal: International journal of urology Issue: Volume 30:Number 2(2023) Page Start: 139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of combination therapy with tamsulosin, dutasteride and imidafenacin for the management of overactive bladder symptoms associated with benign prostatic hyperplasia: A multicenter, randomized, open‐label, controlled trial (DIrecT Study). (2nd May 2017) Authors: Yamanishi, Tomonori; Asakura, Hirotaka; Seki, Narihito; Tokunaga, Shoji Journal: International journal of urology Issue: Volume 24:Number 7(2017) Page Start: 525 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. GreenLight HPS laser 120 W vs diode laser 300 W vaporization of the prostate for the treatment of benign prostatic hyperplasia in Japanese patients: A prospective, single‐center, randomized clinical trial. Issue 1 (9th June 2020) Authors: Kobayashi, Takeshi; Seki, Narihito; Song, Yoo H.; Dejima, Takashi Journal: LUTS Issue: Volume 13:Issue 1(2021) Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Long‐term safety and efficacy of antimuscarinic add‐on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A multicenter, randomized study in Japan (MILAI II study). (13th December 2018) Authors: Yamaguchi, Osamu; Kakizaki, Hidehiro; Homma, Yukio; Igawa, Yasuhiko; Takeda, Masayuki; Nishizawa, Osamu; Gotoh, Momokazu; Yoshida, Masaki; Yokoyama, Osamu; Seki, Narihito; Okitsu, Akira; Hamada, Takuya; Kobayashi, Akiko; Kuroishi, Kentaro Journal: International journal of urology Issue: Volume 26:Number 3(2019) Page Start: 342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Non‐inferiority of silodosin 4 mg once daily to twice daily for storage symptoms score evaluated by the International Prostate Symptom Score in Japanese patients with benign prostatic hyperplasia: A multicenter, randomized, parallel‐group study. (18th January 2015) Authors: Seki, Narihito; Takahashi, Ryosuke; Yamaguchi, Akito; Ito, Kenji; Takayama, Kazuo; Nanri, Kazushige; Kamiryo, Yoriaki; Yamashita, Hiroshi; Komine, Shinichiro; Miyazaki, Yoshiharu; Uozumi, Jiro; Naito, Seiji Journal: International journal of urology Issue: Volume 22:Number 3(2015) Page Start: 311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Once‐daily oxybutynin patch improves nocturia and sleep quality in Japanese patients with overactive bladder: Post‐hoc analysis of a phase III randomized clinical trial. (17th March 2015) Authors: Yokoyama, Osamu; Yamaguchi, Akito; Yoshida, Masaki; Yamanishi, Tomonori; Ishizuka, Osamu; Seki, Narihito; Takahashi, Satoru; Yamaguchi, Osamu; Higo, Naruhito; Minami, Hidenao; Masegi, Yu Journal: International journal of urology Issue: Volume 22:Number 7(2015) Page Start: 684 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Once‐daily oxybutynin patch improves nocturia and sleep quality in Japanese patients with overactive bladder: Post‐hoc analysis of a phase III randomized clinical trial. (17th March 2015) Authors: Yokoyama, Osamu; Yamaguchi, Akito; Yoshida, Masaki; Yamanishi, Tomonori; Ishizuka, Osamu; Seki, Narihito; Takahashi, Satoru; Yamaguchi, Osamu; Higo, Naruhito; Minami, Hidenao; Masegi, Yu Journal: International journal of urology Issue: Volume 22:Number 7(2015) Page Start: 684 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗